Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival

作者: Ioannis G. Kaklamanos , Oliver F. Bathe , Dido Franceschi , Andreas Ch. Lazaris , Panagiotis Davaris

DOI: 10.1002/(SICI)1096-9098(199912)72:4<225::AID-JSO8>3.0.CO;2-S

关键词:

摘要: Background and Objectives Estrogen receptors (ER) progesterone (PR) have been detected in both normal malignant colonic mucosa, but the prognostic value of this observation is unknown. We aimed to define significance presence ER PR cells from colorectal adenocarcinoma specimens. Methods An immunohistochemical assay for was performed on paraffinized sections 65 specimens. Survival curves were analyzed implications PR. Results Twenty nine (45%) tumors tested receptor positive (32% 23% PR). Tumors advanced stage more likely express than early (56% vs. 32%; P = 0.01). Median survival patients with neoplasms expressing 30 months. For whose did not any receptors, median had reached at time follow-up (P 0.04). Similarly, significantly reduced (median 20 months; 0.003). Conclusions Expression sex steroids correlates disease. Expression by tumor associated a shorter patient survival. The results suggest that may play role carcinogenesis progression. J. Surg. Oncol. 1999;72:225–229. © 1999 Wiley-Liss, Inc.

参考文章(45)
Richard W. Brown, Lauri Brozo Campagna, J. Kay Dunn, Philip T. Cagle, Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. American Journal of Clinical Pathology. ,vol. 107, pp. 12- 19 ,(1997) , 10.1093/AJCP/107.1.12
A. Francavilla, A. Di Leo, L. Polimeno, D. Conte, M. Barone, G. Fanizza, C. Chiumarulo, G. Rizzo, M. Rubino, Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue Gastroenterology. ,vol. 93, pp. 1301- 1306 ,(1987) , 10.1016/0016-5085(87)90259-9
Rebecca Troisi, Catherine Schairer, Wong-Ho Chow, Arthur Schatzkin, Louise A. Brinton, Joseph F., Jr. Fraumeni, A prospective study of menopausal hormones and risk of colorectal cancer (United States) Cancer Causes & Control. ,vol. 8, pp. 130- 138 ,(1997) , 10.1023/A:1018455810238
G Castoria, A Migliaccio, F Auricchio, M Di Domenico, A Bilancio, Estradiol Activation of Human Colon Carcinoma-derived Caco-2 Cell Growth Cancer Research. ,vol. 56, pp. 4516- 4521 ,(1996)
Bruce S. Schoenberg, Richard A. Greenberg, Henry Eisenberg, Occurrence of Certain Multiple Primary Cancers in Females2 JNCI: Journal of the National Cancer Institute. ,vol. 43, pp. 15- 32 ,(1969) , 10.1093/JNCI/43.1.15
Ellen Kampman, John D. Potter, Martha L. Slattery, Bette J. Caan, Sandra Edwards, Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States Cancer Causes & Control. ,vol. 8, pp. 146- 158 ,(1997) , 10.1023/A:1018459911147
Joseph F Fraumeni Jr, J William Lloyd, Elizabeth M Smith, Joseph K Wagoner, Cancer Mortality Among Nuns: Role of Marital Status in Etiology of Neoplastic Disease in Women Journal of the National Cancer Institute. ,vol. 42, pp. 455- 468 ,(1969) , 10.1093/JNCI/42.3.455
Avima M. Ruder, Flora Lubin, Yochanan Wax, Abraham Geier, Esther Alfundary, Angela Chetrit, Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences Cancer. ,vol. 64, pp. 196- 202 ,(1989) , 10.1002/1097-0142(19890701)64:1<196::AID-CNCR2820640134>3.0.CO;2-3
P. A. Newcomb, B. E. Storer, Postmenopausal Hormone Use and Risk of Large-Bowel Cancer Journal of the National Cancer Institute. ,vol. 87, pp. 1067- 1071 ,(1995) , 10.1093/JNCI/87.14.1067